Avita Medical Inc - Company Profile
Powered by 
All the sales intelligence you need on Avita Medical Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Avita Medical Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Avita Medical Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Avita Medical Inc (Avita Medical) is a commercial-stage regenerative medical device company. The company develops products to meet the unmet medical needs of patients in conditions such as burns and chronic wounds, besides aesthetics and skin defects. Its lead product is RECELL System, a single-use (disposable) stand-alone, battery-operated device, which is approved for the treatment of acute thermal burns in adult patients, and also for treating vitiligo and full-thickness skin defects in the US. The company's proprietary application technology provides treatment harnessing the regenerative properties of the skin of patients. The company has operations in the US, Australia, Japan, and the UK, besides the European Union. Avita Medical is headquartered in Valencia, California, the US.
Headquarters
United States of America
Address
28159 Avenue Stanford, Suite 220, Valencia, California, 91355
Website
www.avitamedical.com
Telephone
1 833 4628482
No of Employees
226
Industry
Medical Equipment
Ticker Symbol & Exchange
RCEL (NASD)
Revenue (2024)
$71.6M
11.5%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
21.4%
(2024 vs 2023)
Market Cap*
$135.7M
Net Profit Margin (2024)
XYZ
29.5%
(2024 vs 2023)
* As of and is in US$
Avita Medical Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | - |
| The RECELL Autologous Cell Harvesting System (RECELL System) | RECELL |
| Spray Delivery of Single Living Cells for Epidermal Regeneration | RECELL Go |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Others | In September, the company received the CE Mark under the European Union Medical Device Regulation for RECELL GO in Europe and other markets. |
| 2025 | New Products/Services | In April, the company announced the launch of Cohealyx, a collagen-based dermal matrix. |
| 2025 | Contracts/Agreements | In March, the company entered into manufacturing and distribution agreement with Stedical Scientific for its PermeaDerm Biosynthetic Wound Matrix. |
Competitor Comparison
| Key Parameters | Avita Medical Inc | Johnson & Johnson | Smith & Nephew Plc | Molnlycke Health Care AB | Integra LifeSciences Holdings Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United Kingdom | Sweden | United States of America |
| City | Valencia | New Brunswick | Watford | Gothenburg | Princeton |
| State/Province | California | New Jersey | England | Vastra Gotaland | New Jersey |
| No. of Employees | 226 | 138,200 | 17,349 | 8,617 | 4,427 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Cary Vance | Interim Chief Executive Officer; Chairman | Executive Board | 2025 | 60 |
| David O’Toole | Chief Financial Officer | Senior Management | 2023 | 67 |
| Nicole Kelsey | Chief Compliance Officer; Chief Legal and Compliance Officer | Senior Management | 2024 | 59 |
| Debbie Garner | Senior Vice President - Global Marketing & Strategy | Senior Management | 2023 | - |
| Robin VanDenburgh | Senior Vice President - U.S. Commercial Sales | Senior Management | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer